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Abstract
Brucellosis is considered the major zoonosis in developing countries. In susceptible ani‐
mal species, diagnosis of brucellosis remains a challenge due to the variety of clinical
signs that it shares with a wide range of diseases. At present, isolation of Brucella is con‐
sidered the gold standard for diagnosis of brucellosis; because of its low sensitivity and be‐
coming potentially hazardous to laboratory technicians, serology is used for the detection
of specific antibodies induced by infection. However, since traditional methods common‐
ly show drawbacks and do not differentiate between vaccinated and naturally infected
animals, it is necessary to search and test immunoreactive molecules for specific diagno‐
sis of Brucella-infected cattle, thus significantly reducing the killing of suspected herds
mainly due to vaccination. Advances in biotechnology have allowed exploring the use of
recombinant proteins as antigens to avoid the risk involved in the use of viable Brucella
strains. The benefit of using recombinant proteins, such as outer membrane proteins
(OMP) and other non-lipopolysaccharide (non-LPS) molecules as antigens, for serological
diagnosis is promising, but there are still many concerns about their application. The aim
of the present work is to show advances in the use of recombinant antigens and discuss
their advantages and potential use as markers for the serological diagnosis in brucellosis.
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1. Introduction
1.1. Diagnosis of brucellosis
Brucellosis is a zoonosis caused by bacteria of the genus Brucella, which is characterized by
gram-negative coccobacilli, intracellular facultative, and slow-growing bacteria that do not
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have capsule or form spores [1]. Since clinical signs of brucellosis are not pathognomonic,
diagnosis is dependent upon demonstration of the presence of Brucella spp. by microbiology,
polymerase chain reaction (PCR), detection of its antigens, and demonstration of specific
antibody or cell-mediated immune responses [2, 3]. At present, isolation of Brucella is consid‐
ered the gold standard, but it has low sensitivity and is hazardous to laboratory technicians,
therefore, serology is the most common method for the diagnosis of brucellosis.
Brucellosis serology is usually performed using antigens derived from B. abortus S19 strain,
because the Brucella immunodominant antigens associated to the smooth-lipopolysaccharide
(S-LPS) are to a large extent shared by all naturally occurring biovars of the so-called “smooth
species,” B. abortus, B. melitensis, B. suis, B. neotomae, B. ceti, and B. pinnipedialis [4]. Unfortu‐
nately, because of the LPS sharing, conventional methods do not differentiate between the
smooth B.abortus S19 vaccinated and naturally infected animals; in addition, there could be
cross reaction with other gram negative bacteria, such as Escherichia coli O157:H7 and Yersinia
enterocolitica, because of their LPS similarity [7], thus affecting the specificity (Sp) of the test.
The rough RB 51 B. abortus vaccine lacks the OPS, which avoids false reactions.
Various tests are generally used to improve the final specificity, in which an initial screening
assay, such as the buffered Brucella antigen, the rose Bengal (RBT),the buffered plate aggluti‐
nation (BPAT)or the indirect ELISA tests, which possess high sensitivity and relative specif‐
icity, are used to select reactive samples, followed by a secondary confirmatory test,with higher
specificity than the screening test, such asthe complement fixation test (CFT), rivanol. Other
modern tests can also be used including the fluorescence polarization assay (FPA) [3, 5, 8].
ELISA and FPA may be used for diagnosis [20], because of their high performance.On the other
hand, since B. canis and B. ovis, known as “rough species” lack LPS, the CFT, agar gel immu‐
nodiffusion (AGID) test, and indirect ELISA (I-ELISA) using soluble surface antigens obtained
from B. ovis, are preferred [6].
2. Immunodominant antigens
The following immunodominant antigens have been identified within the genus Brucella: (a)
S-LPS (smooth lipopolysaccharide), (b) R-LPS (rough lipopolysaccharide), (c) outer membrane
proteins (OMP), and (d) periplasmic and cytoplasmic proteins [9].
2.1. Brucella spp lipopolysaccharide
Lipopolysaccharide present in smooth species of Brucella comprises a glycolipid portion (lipid
A) inserted in the outer membrane and a polysaccharide directed outward. The latter is divided
into two sections: the core and the O-chain. Brucella ovis and B. canis naturally lack O-chain
(OPS), whereas B. melitensis, B. abortus, and B. suis might lose it by mutation. S-LPS is markedly
immunodominant on the serological response, therefore, most serological tests are focused on
detecting antibodies to S-LPS and the use of bacterial suspensions or antigens without OPS
leads to misdiagnosis [10].
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2.1.1. Brucella outer membrane proteins
Although Brucella species are genetically closely related, there are differences in pathogenic‐
ity  and  host  preference  that  may  be  favored,  at  least  in  part,  by  the  outer  membrane
structure [11], mainly composed by LPS and OMPs. Since LPS of rough Brucella species (B.
ovis, B. canis, and B. abortus RB51) lacks OPS, OMPs are more exposed on the surface and
their  role  in  the  virulence  of  the  bacteria  has  become very  important  in  the  search  for
antigens that can be used in the development of vaccines or diagnostic methods [12]. Brucella
OMPs were initially identified and classified according to their molecular weight [13]. Thus,
membrane proteins that  are within group 1 have molecular weights between 88 and 94
kDa, group 2 (omp2a and omp2b) from 36 to 38 kDa, and group 3, comprising omp25 and
omp31,  from 25 to  27  and 31  to  34  kDa,  respectively  [14].  In  Brucella,  major  OMPs are
Omp25 and Omp31 (belonging to group 3), except in B. abortus where it has been demon‐
strated by molecular techniques the missing omp31 gene encoding this protein [15]. One
study [16] reported that there is a good reactivity against Omp31 protein extracted from B.
ovis in sheep sera, experimentally infected with the bacteria and with specific monoclonal
anti-Omp31 antibodies, but little reactivity against Omp31 protein recombinant B. meliten‐
sis.  This  feature is  attributed to the existence of  differences in nine nucleotides between
omp31  genes of both Brucella  strains that strongly modify the antigenic properties of the
encoded  proteins  [5],  suggesting  that  this  protein  may  be  useful  as  antigen  for  the
development of specific tests for the detection of infectious epididymitis caused by B. ovis
in  rams.  Moreover,  Omp28,  also  known  as  CP28  or  BP26,  has  been  identified  as  an
immunodominant antigen in infected cattle, sheep, goats, and humans and could be useful
for the detection of anti-Brucella humoral responses of infected animals [17].
On  the  other  hand,  8  immuno-reactive  non-LPS  proteins  were  identified  [18]  using
proteomics  and then  tested  with  Brucella-positive  sera  by  ELISA and showed no  cross-
reaction to Escherichia coli O157: H7, Yersinia enterocolitica, or negative serum to B. abortus.
Of  these  proteins,  chaperonin  GroES  (21  kDa)  and  DnaK  (71.2  kDa)  showed  high  im‐
mune reactivity and therefore the greatest potential as diagnostic antigens. In addition, 18
immunodominant insoluble proteins of Brucella abortus were separated by two-dimension‐
al  electrophoresis  (2-DE)  and their  immune-reactivity  was  tested against  the  antisera  of
cattle infected with B. abortus, or/and Yersinia enterocolitica, or the sera of non-infected cattle
using Western blotting. A wide variety of these insoluble proteins were identified by MS/MS
analysis as F0F1 ATP synthase subunit b,  solute-binding family 5 protein, 28 kDa OMP,
Leu/Ile/Val-binding family protein,  histidinol  dehydrogenase,  hypothetical  protein,  twin-
arginine  translocation  pathway  signal  sequence  domain-containing  protein,  serine  pro‐
tease  family  protein,  b-hydroxyacyl-(acyl-carrier-protein)  dehydratase  FabA,  short  chain
dehydrogenase-/reductase  carbonic  anhydrase,  ornithine  carbamoyltransferase,  leucyl
aminopeptidase,  cold shock DNA-binding domain-containing protein,  Cu/Zn superoxide
dismutase, and methionine aminopeptidase [19].
2.2. Recombinant antigens in serology of brucellosis
Advances in biotechnology have allowed exploring the use of recombinant proteins as
antigens to avoid the risk involved in the use of viable Brucella strains. An extremely useful
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application of proteomics to the diagnosis of infectious disease relies on the identification of
novel diagnostic antigens by screening serum from infected and uninfected individuals against
immunoblotted, 2-DE mapped proteomes of infectious agents [20]. Once those antigens are
identified, due to easy production of recombinant proteins in prokaryotic systems, a wide
variety of non-LPS molecules are cloned and expressed in the Escherichia coli system to obtain
recombinant immune-reactive proteins. The most studied OMPs belong to group 3 (Omp25
and Omp31); recombinant Omp31 protein (rOmp31) obtained from Brucella melitensis
expressed in the Escherichia coli system showed reactivity in Brucella positive sera, but not in
Brucella negative sera, in a variety of animal species by iELISA. However, the sensitivity and
specificity of each affected species showed significant difference [14]. iELISA performed with
rOmp31 showed lower sensitivity (85%) and higher specificity (100%), compared with
conventional rose Bengal plate test (RBPT), with 92% and 83%, respectively [21]. Other studies
found that recombinant B. melitensis rOMP28 was immunoreactive to Brucella infected cattle,
sheep, goat, and dog sera with a sensitivity of 88.7%, specificity of 93.8%, and accuracy of 92.9%
by iELISA, demonstrating that it could be used as an antigen for diagnosis of brucellosis in
domestic animals [22].
Furthermore, B. abortus Omp28 coding gene was cloned and expressed using the pMAL
system, and rOmp28 was evaluated for its potential use in the serodiagnosis of bovine
brucellosis by iELISA and the latex bead agglutination test (LAT). The sensitivity, specificity,
and accuracy were 96.7%, 95.4%, 96.2% in iELISA and 77%, 80.6%, and 78.5% in latex bead
agglutination test, respectively [23]. In addition, recombinant BP26 was produced in the E.
coli system and tested by iELISA, but it resulted less useful than iELISA using the B. ovis hot
saline (HS) extract as antigen [24, 25]. On the other hand, ribosome recycling factor protein
CP24 and Brucella lumazine synthase (BLS) showed antigen-antibody interaction by iELISA,
using brucellosis positive sera, and therefore it could be considered as a potential alternative
diagnostic [26].
Other studies focused in the type IV secretion system (T4SS) encoded by the virB locus, located
on chromosome II, including virB1 to virB12 [27], obtained recombinant VirB5 protein by a
prokaryotic expression system, which was used to detect anti-Brucella antibodies by ELISA, in
both standard brucellosis-positive serum and cattle sera samples; the results showed that
recombinant VirB5 protein had good immune-reactivity [27]. In addition, in order to investi‐
gate the practical value of VirB5 in clinical applications, serum samples from cattle were
screened using the VirB5-ELISA; the sensitivity of the VirB5-ELISA was 88.2% and the
specificity was 97.8%. In all test samples, the accuracy reached 94.8%. Thus, these results
confirmed the importance of VirB5 as a suitable antigen and VirB5-ELISA as screening test for
the serological diagnosis of bovine brucellosis [27]. Another study was developed by Rolan et
al. in 2008 [28], evaluating recombinant VirB1, VirB5, VirB11, and VirB12 by antibodies in sera
from experimentally infected mice and goats by iELISA. Antibody responses to VirB12 but not
to VirB1, VirB5, or VirB11 were detected in mice experimentally inoculated with B. abortus and
goats experimentally infected with Brucella melitensis.
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3. Conclusion
At present, FAO-OIE-WHO work together in strategies to prevent a worldwide emergent, re-
emergent, and cross-border spread of human and animal infectious diseases [29]. Brucellosis
remains a major zoonotic disease in the world and its control and eradication will be possible
only with the complete collaboration of all sectors involved in health and animal production.
As a significant part of the strategy, One World-One Health (OWOH) [30] involves early
diagnosis of infected animals. Conventional serological tests have performance differences due
to a variety of factors, including sample condition, vaccinated status, wide spread, and others.
Therefore, it is necessary to search immune-reactive molecules that prevent faulty results that
could compromise campaigns of control and eradication of this disease. The aim of this work
is to bring together advances in the use of recombinant antigens, their problems, and perspec‐
tives as potential markers for the serological diagnosis in brucellosis. It is known that a test
based on recombinant proteins would allow better standardization of the assay, compared
with more complex whole-cell antigen preparations currently in use, and hence overcome the
limitations associated with the use of LPS-based antigens, but finding results still not optimal
(Table 1). Many of the failures in performance found in the analyzed studies might originate
due to denaturing conditions in purification or Western blotting that could affect on the tertiary
structure of the recombinant protein, and hence to immune-dominant epitopes, or by a low
adherence to polystyrene plaque in the ELISA test. In addition, the expression of immune-
dominant proteins could be different between in vitro and in vivo culture conditions and then
results obtained would be distinct in sera from animals naturally infected with field strains
compared with experimentally infected animals. Therefore, the search of alternative purifica‐
tion techniques to the ones currently used that retains the structural integrity of the protein is
essential. Furthermore, standardization of homogeneous diagnostic tests as FPA [31], which
minimize the subjective factor involved in the interpretation of results found in agglutination
tests, could be helpful in the control and eradication programs worldwide.
Test Sensitivity (%) Specificity (%) Animal specie
RBTa 21.0–98.3 68.8–100 Cattle
iELISAa 92.5–100 90.6–100 Cattle
CFTa 23.0–97.1 30.6–100 Cattle
FPAa 99.0–99.3 96.9–100 Cattle
FPAb 85.7% 99% Goat
rOmp31-iELISAC 85 100 Goat
B. melitensis rOMP28-iELISAd 88.7 93.8 Cattle, sheep, goat, and dog
B. abortus rOmp28-iELISAe 96.7 95.4 Cattle
rVirB5-ELISAf 88.2 97.8 Cattle
a. [8]; b; [31]c. [21]; d. [22]; e. [23]; f. [27].
Table 1. Sensitivity and specificity of serological tests for brucellosis with conventional and recombinant antigens
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